Concepedia

FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease

Bellinda L. King‐Kallimanis, Tanya Wroblewski, Virginia E. Kwitkowski, R. Angelo de Claro, Thomas Gwise, Vishal Bhatnagar, Ann T. Farrell, Paul G. Kluetz

Quality of Life Research · 2020 · 22 citations · 14 references

DOI

Concepts

References

14

The National Comprehensive Cancer Network

William T. McGivney · Cancer · 1998 · 16.9K citations

, , +15

Interpreting the significance of changes in health-related quality-of-life scores.

David Osoba, George Rodrigues, James D. Myles et al. · Journal of Clinical Oncology · 1998 · 2.9K citations

, , +16

Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

John R. Wingard, Navneet S. Majhail, Ruta Brazauskas et al. · Journal of Clinical Oncology · 2011 · 627 citations · Full text

, , +16

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Steven Z. Pavletic, Paul J. Martin, Stephanie J. Lee et al. · Biology of Blood and Marrow Transplantation · 2006 · 565 citations · Full text

, , +12

Ibrutinib for chronic graft-versus-host disease after failure of prior therapy

David B. Miklos, Corey Cutler, Mukta Arora et al. · Blood · 2017 · 499 citations · Full text

, , +11